Poxel S.A. (EPA:POXEL)
France
· Delayed Price · Currency is EUR 0.249
+0.002 (0.61%)
Mar 6, 2026, 5:35 PM CET
Poxel Employees
Poxel had 5 employees as of June 30, 2025. The number of employees decreased by 1 or -16.67% since the number was reported on December 31, 2024.
Employees
5
Change
-1
Growth
-16.67%
Revenue / Employee
€1,531,400
Profits / Employee
€2,732,800
Market Cap
13.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NFL Biosciences | 5 |
| Oncodesign Precision Medicine Société anonyme | 14 |
| Aelis Farma | 24 |
| Plant Advanced Technologies | 16 |
| GenSight Biologics | 13 |
| genOway Société anonyme | 148 |
| TME Pharma | 12 |
| Advicenne | 13 |
Poxel News
- 19 days ago - Poxel Reports its 2025 Revenue and Provides an Update on its Financial Position - Business Wire
- 4 weeks ago - Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan - Business Wire
- 5 weeks ago - POXEL SA: The Commercial Court of Lyon Approves the Recovery Plan and Brings an End to the Judicial Reorganisation Proceedings - Business Wire
- 3 months ago - Poxel Publishes Its Financial Results for the First Half of 2025 - Business Wire
- 3 months ago - POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar - Business Wire
- 4 months ago - Poxel Reports Revenue for the Third Quarter 2025 - Business Wire
- 4 months ago - Appointment of Yves Decadt as Member of Poxel's Board of Directors - Business Wire
- 5 months ago - Poxel Reports Financial Results for Full Year 2024 and Provides Operational and Financial Update - Business Wire